Corvus Pharmaceuticals, Inc. CRVS
Set alert
10.03 USD -0.20 -1.96%
At close · Oct 30
10.03 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
9.78 Day range 10.37
6.50 52-week range 25.52
- YTD
- +30.26%
- 1 year
- +29.25%
- Open
- 10.09
- Prev close
- 10.23
- Mkt cap
- 843.73M
- Vol
- 845.13K
- Avg vol
- 1.00M
- EPS
- -0.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.78
- High
- 10.37
- Forward P/E
- -11.75
- Beta
- 0.86
- Short ratio
- 25.31
- Inst. own
- 85.73%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 13.94
- 200-d avg
- 14.03
- 1y target
- 33.14
Ownership
Held by insiders 3.51%
Held by institutions 85.73%
Float held by institutions 88.84%
Institutions 235
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC. | 8.52% | 7,165,006 | 89.85M | Jun 29, 2026 |
| Blackrock Inc. | 8.49% | 7,138,811 | 89.52M | Jun 29, 2026 |
| State Street Corporation | 5.32% | 4,474,091 | 56.11M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 4.50% | 3,789,126 | 47.52M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 3.91% | 3,292,710 | 41.29M | Jun 29, 2026 |
| Adams Street Partners, LLC | 3.89% | 3,275,616 | 41.08M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.68% | 3,094,939 | 38.81M | Aug 30, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.82% | 2,374,106 | 29.77M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.06% | 1,733,385 | 21.74M | Jul 30, 2026 |
| Manager Directed Portfolios-Hood River Small-Cap Growth Fund | 1.94% | 1,632,008 | 20.47M | Jul 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.15% | 963,958 | 12.09M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.00% | 844,722 | 10.59M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JONES WILLIAM BENTON | Officer | Conversion of Exercise of derivative security | Jun 3, 2025 | 173,130 |
| MILLER RICHARD A | Chief Executive Officer | Purchase | May 17, 2026 | 0 |
| MOORE DAVID SCOTT | Director | Purchase | Jun 10, 2026 | 21,700 |
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 26, 2025 | 0 |
| THOMPSON PETER A | Director and Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 26, 2025 | 0 |
Held by funds
87 US ETFs and mutual funds hold CRVS · largest positions